Disease | renal cell carcinoma |
Comorbidity | C0494165|liver metastases |
Sentences | 3 |
PubMedID- 24090151 | Whether liver damage occurs in patients with liver metastases of renal cell carcinoma after sunitinib administration is not yet known. |
PubMedID- 24061106 | So it seems that when using lesion size for treatment assessment, a threshold of −10% instead of −30% is better at distinguishing responders from non-responders among patients with mrcc receiving targeted therapy.figure 1liver metastases in a patient with renal cell cancer (a) before and (b) after sunitinib therapy. |
PubMedID- 23962746 | Impact of bone and liver metastases on patients with renal cell carcinoma treated with targeted therapy. |
Page: 1